An Exploratory, Phase IIa Cross-Over Study to Demonstrate the Efficacy and Safety of A4250 in Patients with Primary Biliary Cirrhosis and Cholestatic Pruritus

Trial Profile

An Exploratory, Phase IIa Cross-Over Study to Demonstrate the Efficacy and Safety of A4250 in Patients with Primary Biliary Cirrhosis and Cholestatic Pruritus

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs A 4250 (Primary)
  • Indications Primary biliary cirrhosis; Pruritus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 Oct 2016 Status changed from recruiting to discontinued.
    • 18 Feb 2016 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017 as reported by ClinicalTrials.gov
    • 18 Feb 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top